Heska Corporation (NASDAQ: HSKA), a leading global provider of advanced veterinary diagnostic and specialty solutions, will reveal its fourth quarter and full year 2022 financial performance on Tuesday, February 28, 2023. Join Heska for an exciting earnings call at 9 a.m. MT / 11 a.m. ET to hear the results and learn more about the Company’s progress. Get ready to dive into Heska’s financial performance and the exciting opportunities ahead!
Join us for our upcoming Heska Fourth Quarter and Full Year Earnings Call Webcast, live from our investor relations website! Get ready to hear all the exciting news and updates on our financial performance. Don’t miss out on this unique opportunity to gain valuable insights into our company!
A replay of the call will be available from 2 p.m. ET on February 28th to 11:59 p.m. ET on March 14th, 2023. Plus, the webcast will be stored on our website for an entire 90 days, giving you plenty of time to catch up on the call.
Heska Corporation (NASDAQ: HSKA) is a leader in providing diagnostic and specialty products and solutions for veterinary practitioners. Their portfolio includes point-of-care diagnostic laboratory instruments and consumables, digital cytology services, digital imaging diagnostic products, local and cloud-based data services, practice information management software (“PIMS”) and related software and support, reference laboratory testing, allergy testing and immunotherapy, heartworm preventive products and vaccines. With a strategic focus on point-of-care diagnosis, Heska’s business is divided into two operating and reportable segments: North America, including the US, Canada, and Mexico, and International, primarily in Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. In addition to diagnostic products, they also provide contract manufacturing of vaccines and pharmaceuticals, and a small veterinary laboratory.